PI
EW icon

PGGM Investments’s Edwards Lifesciences EW Stock Holding History

PGGM Investments’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,172
Closed -$208K – 360
2024
Q1 		$208K Buy
+2,172
New +$182K ﹤0.01% 348
2023
Q2 		– Sell
-7,829
Closed -$648K – 378
2023
Q1 		$648K Buy
7,829
+1,679
+27% +$132K 0.01% 358
2022
Q4 		$459K Sell
6,150
-19,640
-76% -$1.51M 0.01% 352
2022
Q3 		$2.13M Buy
+25,790
New +$2.48M 0.04% 293
2022
Q1 		$21.8M Hold
168,654
– – 0.11% 183
2021
Q4 		$21.8M Buy
168,654
+1,712
+1% +$200K 0.11% 183
2021
Q3 		$18.9M Buy
166,942
+36,289
+28% +$4.14M 0.1% 222
2021
Q2 		$13.5M Sell
130,653
-32,724
-20% -$3.08M 0.06% 249
2021
Q1 		$13.7M Buy
163,377
+25,758
+19% +$2.18M 0.06% 254
2020
Q4 		$12.6M Buy
+137,619
New +$11.4M 0.06% 258
2018
Q1 		– Sell
-161,091
Closed -$6.05M – 286
2017
Q4 		$6.05M Hold
161,091
– – 0.03% 275
2017
Q3 		$5.87M Hold
161,091
– – 0.03% 326
2017
Q2 		$6.35M Sell
161,091
-84,000
-34% -$3.07M 0.03% 327
2017
Q1 		$7.68M Hold
245,091
– – 0.04% 302
2016
Q4 		$7.66M Hold
245,091
– – 0.04% 302
2016
Q3 		$9.85M Hold
245,091
– – 0.05% 283
2016
Q2 		$8.15M Buy
245,091
+121,866
+99% +$4.17M 0.04% 291
2016
Q1 		$3.62M Sell
123,225
-399,159
-76% -$11M 0.02% 366
2015
Q4 		$13.8M Sell
522,384
-5,676
-1% -$147K 0.07% 271
2015
Q3 		$12.5M Sell
528,060
-8,460
-2% -$204K 0.07% 274
2015
Q2 		$12.7M Sell
536,520
-34,122
-6% -$770K 0.07% 284
2015
Q1 		$13.5M Sell
570,642
-58,626
-9% -$1.32M 0.06% 299
2014
Q4 		$13.4M Sell
629,268
-27,174
-4% -$546K 0.06% 300
2014
Q3 		$11.2M Buy
656,442
+22,152
+3% +$350K 0.05% 306
2014
Q2 		$9.07M Buy
+634,290
New +$8.6M 0.04% 319

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

PGGM Investments's EW Position: Q2 2024 in Review

PGGM Investments sold out of Edwards Lifesciences (EW) in Q2 2024, closing a stake of 2,172 shares — an estimated $208K sold.

PGGM Investments first reported a position in EW in Q2 2014 and held it in 25 quarters. The position peaked at $21.8M in Q1 2022. 1,297 funds tracked by Wall St. Rank hold EW as of Q2 2024.

  • PGGM Investments reported no remaining Edwards Lifesciences position as of Q2 2024 after selling out during the quarter.
  • PGGM Investments sold 2,172 Edwards Lifesciences shares in Q2 2024, an estimated $208K.
  • PGGM Investments first reported a position in Edwards Lifesciences in Q2 2014 and held it in 25 quarters.
  • PGGM Investments's Edwards Lifesciences position peaked at $21.8M in Q1 2022.
  • 1,297 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on PGGM Investments's 13F filing for Q2 2024, filed 16 Jul 2024.